MitoQ alleviates mitochondria damage in sepsis-acute lung injury in a citrate synthase dependent manner

Area of Science:

• Biomedical Science
• Mitochondrial Medicine
• Inflammation Research

Background:

• Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection.
• Acute lung injury (ALI) is a common and severe complication of sepsis, particularly affecting the lungs.
• Mitoquinone Mesylate (MitoQ), a mitochondria-targeted antioxidant, shows potential for mitigating oxidative stress.

Purpose of the Study:

• To investigate the protective effects of MitoQ against sepsis-induced ALI.
• To elucidate the underlying mechanisms of MitoQ's action in sepsis-induced ALI.
• To assess MitoQ's impact on mitochondrial function and oxidative stress in pulmonary macrophages.

Main Methods:

• Establishment of a cecal ligation and puncture (CLP) mouse model to induce sepsis.
• Oral administration of MitoQ to mice for two weeks.
• Assessment of lung tissue damage, inflammatory markers, oxidative stress, and apoptosis.
• Evaluation of mitochondrial function and citrate synthase (CS) levels in lung tissues and pulmonary macrophages.
• Gene silencing of CS using siRNA to confirm its role in MitoQ's protective effects.

Main Results:

• MitoQ significantly alleviated sepsis-induced lung tissue damage, inflammation, oxidative stress, and apoptosis.
• MitoQ inhibited oxidative stress and mitochondrial damage in pulmonary macrophages.
• MitoQ upregulated citrate synthase (CS) mRNA and protein levels in lung tissues and pulmonary macrophages.
• Silencing CS expression attenuated the protective effects of MitoQ.

Conclusions:

• MitoQ demonstrates significant protective effects against sepsis-induced ALI.
• MitoQ preserves mitochondrial function and reduces oxidative stress in the context of sepsis.
• The mechanism involves the upregulation of citrate synthase, highlighting its role in MitoQ's therapeutic benefits for ALI.